BlackRock »

An2 Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $322k 301k 1.07

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding An2 Therapeutics

BML Capital Management
RA Capital Management
TCG Crossover Management
Henderson Group
Vanguard Group
Acuitas Investments
Renaissance Technologies
BlackRock
BlackRock
Goldman Sachs Group
Geode Capital Management
Ghost Tree Capital
Two Sigma Advisers
Two Sigma Investments
Bridgeway Capital Management

View all funds holding An2 Therapeutics